These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37539932)

  • 1. Engineering Platelet Membrane Imitating Nanoparticles for Targeted Therapeutic Delivery.
    Adhalrao SB; Jadhav KR; Patil PL; Kadam VJ; Nirmal MK
    Curr Pharm Biotechnol; 2024; 25(10):1230-1244. PubMed ID: 37539932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy.
    Kunde SS; Wairkar S
    Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle biointerfacing by platelet membrane cloaking.
    Hu CM; Fang RH; Wang KC; Luk BT; Thamphiwatana S; Dehaini D; Nguyen P; Angsantikul P; Wen CH; Kroll AV; Carpenter C; Ramesh M; Qu V; Patel SH; Zhu J; Shi W; Hofman FM; Chen TC; Gao W; Zhang K; Chien S; Zhang L
    Nature; 2015 Oct; 526(7571):118-21. PubMed ID: 26374997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet mimicry: The emperor's new clothes?
    Moghimi SM; Hunter AC; Peer D
    Nanomedicine; 2016 Jan; 12(1):245-8. PubMed ID: 26409192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer.
    Pei W; Huang B; Chen S; Wang L; Xu Y; Niu C
    Int J Nanomedicine; 2020; 15():10151-10167. PubMed ID: 33363371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy.
    Yang L; Zhang K; Zheng D; Bai Y; Yue D; Wu L; Ling H; Ni S; Zou H; Ye B; Liu C; Deng Y; Liu Q; Li Y; Wang D
    Int J Nanomedicine; 2023; 18():6293-6309. PubMed ID: 37954456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct attachment of nanoparticle cargo to Salmonella typhimurium membranes designed for combination bacteriotherapy against tumors.
    Kazmierczak R; Choe E; Sinclair J; Eisenstark A
    Methods Mol Biol; 2015; 1225():151-63. PubMed ID: 25253255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and their biomimetics for regenerative medicine and cancer therapies.
    Li Z; Hu S; Cheng K
    J Mater Chem B; 2018 Dec; 6(45):7354-7365. PubMed ID: 31372220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications.
    Choi B; Park W; Park SB; Rhim WK; Han DK
    Methods; 2020 May; 177():2-14. PubMed ID: 31874237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer.
    Zhou M; Lai W; Li G; Wang F; Liu W; Liao J; Yang H; Liu Y; Zhang Q; Tang Q; Hu C; Huang J; Zhang R
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25635-25648. PubMed ID: 34038097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
    Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
    Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology: Platelet mimicry.
    Farokhzad OC
    Nature; 2015 Oct; 526(7571):47-8. PubMed ID: 26375011
    [No Abstract]   [Full Text] [Related]  

  • 14. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
    Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered biomembrane-derived nanoparticles for nanoscale theranostics.
    Wu Z; Zhang H; Yan J; Wei Y; Su J
    Theranostics; 2023; 13(1):20-39. PubMed ID: 36593970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Targeting
    Wang S; Duan Y; Zhang Q; Komarla A; Gong H; Gao W; Zhang L
    Small Struct; 2020 Oct; 1(1):. PubMed ID: 33817693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.
    Dhas N; García MC; Kudarha R; Pandey A; Nikam AN; Gopalan D; Fernandes G; Soman S; Kulkarni S; Seetharam RN; Tiwari R; Wairkar S; Pardeshi C; Mutalik S
    J Control Release; 2022 Jun; 346():71-97. PubMed ID: 35439581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.
    Zhang M; Cheng S; Jin Y; Zhang N; Wang Y
    Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.